Target Price | $114.24 |
Price | $122.00 |
Deviation |
6.36%
register free of charge
|
Number of Estimates | 20 |
20 Analysts have issued a price target Insmed Incorporated 2026 .
The average Insmed Incorporated target price is $114.24.
This is
6.36%
register free of charge
$141.75
16.19%
register free of charge
$99.99
18.04%
register free of charge
|
|
A rating was issued by 25 analysts: 24 Analysts recommend Insmed Incorporated to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insmed Incorporated stock has an average upside potential 2026 of
6.36%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 363.71 | 466.39 |
19.17% | 28.23% | |
EBITDA Margin | -214.87% | -212.03% |
2.97% | 1.32% | |
Net Margin | -251.24% | -244.46% |
2.30% | 2.70% |
19 Analysts have issued a sales forecast Insmed Incorporated 2025 . The average Insmed Incorporated sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Insmed Incorporated EBITDA forecast 2025. The average Insmed Incorporated EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Insmed Incorporated Analysts have issued a net profit forecast 2025. The average Insmed Incorporated net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.57 | -5.40 |
4.31% | 3.05% | |
P/E | negative | |
EV/Sales | 48.39 |
21 Analysts have issued a Insmed Incorporated forecast for earnings per share. The average Insmed Incorporated EPS is
This results in the following potential growth metrics and future valuations:
Insmed Incorporated...
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
UBS |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 22 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Jul 08 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 11 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Jun 11 2025 |
Analyst Rating | Date |
---|---|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
UBS:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 22 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 17 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Jul 08 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 11 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Jun 11 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.